Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management: A Randomized Controlled Double-blinded Clinical Trial.

NCT04441762 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT04441762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04441762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management: A Randomized Controlled Double-blinded Clinical Trial.
Lead sponsor
Oman Medical Speciality Board
Phase
Phase 2/3
Overall status
Completed
Start date
December 30, 2020
Completion date
February 1, 2022
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal colic